Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens
AssigneeCerus Corporation
InventorsSusan Wollowitz, Stephen T. Isaacs, Henry Rapoport, Hans P. Spielmann, Aileen Nerio
Life of this patent
Estimating the term…
Abstract
Psoralen compounds are synthesized which have substitutions on the 4, 4', 5', and 8 positions of the psoralen, which permit enhanced binding to nucleic acid of pathogens. Higher psoralen binding levels and lower mutagenicity are described, resulting in safer, more efficient, and reliable inactivation of pathogens in blood products. The invention contemplates inactivation methods using the new psoralens which do not compromise the function of blood products for transfusion.
Claims23
A method of inactivating pathogens in a composition comprising a blood product, comprising the steps of:
- a) contacting one or more psoralen compounds or salts thereof of formula I, ##STR3## wherein R.sub.1 is --(CH.sub.2).sub.2 --NH.sub.2,
- --(CH.sub.2).sub.w --R.sub.2 --(CH.sub.2).sub.z --NH.sub.2,
- --(CH.sub.2).sub.w --R.sub.2 --(CH.sub.2).sub.x --R.sub.3 --(CH.sub.2).sub.z --NH.sub.2, or
- --(CH.sub.2).sub.w --R.sub.2 --(CH.sub.2).sub.x --R.sub.3 --(CH.sub.2).sub.y --R.sub.4 --(CH.sub.2).sub.z --NH.sub.2 ;
- and R.sub.2, R.sub.3, and R.sub.4 are independently Q or NH.sub.3, and w is a whole number from 1 to 5, x is a whole number from 2 to 5, y is a whole number from 2 to 5, and z is a whole number from 2 to 6;
- R.sub.5, R.sub.6 and R.sub.7 are independently H and (CH.sub.2).sub.v CH.sub.3, and v is a whole number from 0 to 5 in a concentration sufficient to inactivate pathogens upon photoactivation, with a blood product suspected of being contaminated with pathogens;
- and
- b) photoactivating said compound for a duration and at an intensity and a wavelength sufficient to inactivate the pathogens.
Dependencies are inferred from the claim text.